New
Why participate?
Provide an overall view of gene therapy methods, commercialized products, and the development plan for a gene therapy drug
Training Context:
Over the past decade, an increasing number of gene and cell therapy products have reached the market. These therapies are most often intended for rare diseases and follow a development path that differs from small molecules or other biologics.
Interactive Teaching, Case Studies, Experience Sharing
All scientific audiences: R&D managers, project leaders, academic researchers, engineers, technicians, C-suite executives
Fundamental knowledge of biotechnology or molecular biology required
Prices: Excluding tax, as the training is not subject to VAT.
In-house training rate: Please contact us.
There is no rating available because this training session was never carried out.
Registering online or by e-mail is a pre-registration. We will process your request within one week:
Signing the training agreement commits the company or individual to the training course. Cancellation conditions are specified in the training agreement.
When no session date is specified, pre-registration allows us to note your interest in a programme, and we will keep you informed as soon as a new session is organised.
For more information, contact Daphné Brisard: 02 47 36 63 18 or formation@mabdesign.fr
